Stockreport

OS Therapies FDA Meeting Request Granted

OS Therapies Incorporated  (OSTX) 
PDF Written response-only meeting to align analysis plan of surrogate endpoint to support Breakthrough Therapy Designation & Accelerated Approval of OST-HER2 in the Preventi [Read more]